T1	disease_or_phenotypic_feature 0 13	Renal failure
T2	chemical 15 19	drug
T3	chemical 41 45	drug
T4	chemical 54 63	Melatonin
T5	chemical 134 141	hormone
T6	disease_or_phenotypic_feature 142 151	dependent
T7	disease_or_phenotypic_feature 152 165	breast cancer
T8	disease_or_phenotypic_feature 195 212	retinochoroiditis
T9	chemical 229 239	adalimumab
T10	chemical 267 277	antagonist
T11	chemical 326 332	oxygen
T12	disease_or_phenotypic_feature 345 358	renal failure
T13	disease_or_phenotypic_feature 376 387	proteinuria
T14	disease_or_phenotypic_feature 429 436	obesity
T15	chemical 441 451	anesthetic
T16	chemical 487 493	oxygen
T17	chemical 514 524	biomarkers
T18	disease_or_phenotypic_feature 568 585	colorectal cancer
T19	disease_or_phenotypic_feature 610 617	obesity
T20	chemical 639 643	drug
T21	chemical 663 670	antigen
T22	chemical 687 690	DIC
T23	disease_or_phenotypic_feature 687 690	DIC
T24	disease_or_phenotypic_feature 705 718	renal failure
T25	chemical 787 797	plinabulin
T26	chemical 849 859	biological
T27	disease_or_phenotypic_feature 921 925	pain
T28	disease_or_phenotypic_feature 1061 1069	vomiting
T29	disease_or_phenotypic_feature 1071 1078	anxiety
T30	chemical 1080 1086	oxygen
T31	disease_or_phenotypic_feature 1096 1103	seizure
T32	disease_or_phenotypic_feature 1139 1147	melanoma
T33	chemical 1148 1155	antigen
T34	chemical 1162 1170	antigens
T35	chemical 1208 1215	Gelatin
T36	disease_or_phenotypic_feature 1259 1271	hyperthermia
T37	chemical 1285 1297	methotrexate
T38	chemical 1324 1334	inhibitors
T39	disease_or_phenotypic_feature 1368 1387	psoriatic arthritis
T40	disease_or_phenotypic_feature 1408 1417	malignant
T41	chemical 1543 1549	enzyme
T42	chemical 1583 1591	antigens
T43	disease_or_phenotypic_feature 1601 1614	hydrocephalus
T44	disease_or_phenotypic_feature 1631 1644	short stature
T45	chemical 1649 1663	growth hormone
T46	chemical 1705 1709	drug
T47	disease_or_phenotypic_feature 1723 1730	obesity
T48	chemical 1758 1780	angiogenesis inhibitor
T49	chemical 1781 1788	TNP-470
T50	disease_or_phenotypic_feature 1829 1843	lung carcinoma
T51	chemical 1846 1858	Homocysteine
T52	chemical 1859 1868	oxidation
T53	disease_or_phenotypic_feature 1905 1917	cleft palate
T54	chemical 1960 1975	malondialdehyde
T55	chemical 1977 1980	MDA
T56	chemical 1986 1992	sodium
T57	chemical 1993 1998	oxide
T58	disease_or_phenotypic_feature 2010 2013	SOD
T59	disease_or_phenotypic_feature 2123 2136	heart failure
T60	disease_or_phenotypic_feature 2142 2155	heart failure
T61	chemical 2185 2194	oxidative
R1	causes_or_contributes_to Arg1:T5 Arg2:T7	
T62	corrected_disease_or_phenotypic_feature 134 165	hormone-dependent breast cancer
T63	missed_disease_or_phenotypic_feature 112 118	tumors
R2	treats Arg1:T4 Arg2:T63	
R3	treats Arg1:T4 Arg2:T62	
T64	corrected_disease_or_phenotypic_feature 167 212	Acute unilateral toxoplasma retinochoroiditis
R4	causes_or_contributes_to Arg1:T9 Arg2:T64	
T65	missed_chemical 243 264	tumor necrosis factor
R5	causes_or_contributes_to Arg1:T65 Arg2:T64	
T66	corrected_chemical 626 643	anorexigenic drug
R6	treats Arg1:T66 Arg2:T19	
T67	missed_disease_or_phenotypic_feature 884 913	decreases in tumor blood flow
T68	corrected_disease_or_phenotypic_feature 884 896;915 925	decreases in tumor pain
R7	causes_or_contributes_to Arg1:T25 Arg2:T67	
R8	causes_or_contributes_to Arg1:T25 Arg2:T68	
T69	missed_chemical 1016 1020	HBOT
T70	missed_disease_or_phenotypic_feature 1032 1051	otologic barotrauma
T71	missed_disease_or_phenotypic_feature 1053 1059	nausea
T72	missed_disease_or_phenotypic_feature 1080 1095	oxygen toxicity
T73	missed_disease_or_phenotypic_feature 1109 1123	myopic changes
R9	causes_or_contributes_to Arg1:T69 Arg2:T70	
R10	causes_or_contributes_to Arg1:T69 Arg2:T71	
R11	causes_or_contributes_to Arg1:T69 Arg2:T28	
R12	causes_or_contributes_to Arg1:T69 Arg2:T29	
R13	causes_or_contributes_to Arg1:T69 Arg2:T72	
R14	causes_or_contributes_to Arg1:T69 Arg2:T31	
R15	causes_or_contributes_to Arg1:T69 Arg2:T73	
T75	corrected_disease_or_phenotypic_feature 1361 1387	active psoriatic arthritis
R17	treats Arg1:T37 Arg2:T75	
T76	corrected_chemical 1302 1334	tumor necrosis factor inhibitors
R18	treats Arg1:T76 Arg2:T75	
T77	missed_chemical 1494 1513	chemical substances
T78	corrected_disease_or_phenotypic_feature 1408 1427	malignant neoplasia
R19	causes_or_contributes_to Arg1:T77 Arg2:T78	
R20	treats Arg1:T46 Arg2:T47	
T79	corrected_disease_or_phenotypic_feature 1823 1843	Lewis lung carcinoma
R21	treats Arg1:T48 Arg2:T79	
R22	treats Arg1:T49 Arg2:T79	
T80	corrected_disease_or_phenotypic_feature 1792 1804;1820 1843	tumor growth of Lewis lung carcinoma
R23	treats Arg1:T48 Arg2:T80	
R24	treats Arg1:T49 Arg2:T80	
T81	corrected_disease_or_phenotypic_feature 1809 1843	metastasis of Lewis lung carcinoma
R25	treats Arg1:T48 Arg2:T81	
R26	treats Arg1:T49 Arg2:T81	
T82	missed_disease_or_phenotypic_feature 2046 2063	tumor progression
R27	causes_or_contributes_to Arg1:T54 Arg2:T82	
R28	causes_or_contributes_to Arg1:T55 Arg2:T82	
